| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
olfactory receptor family 4 subfamily C member 15 | 6.5E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||||
|
olfactory receptor family 5 subfamily BE member 1 pseudogene |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||||||||
|
calcium voltage-gated channel auxiliary subunit beta 2 | 0.659 | 0.538 | 2.7E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2011 | 2011 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 0.475 | 0.846 | 0.94 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
Wnt family member 3 | 0.536 | 0.808 | 0.88 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
usherin | 0.579 | 0.692 | 1.6E-94 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
ZBTB44 divergent transcript |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | |||||||||||
|
nucleoredoxin | 0.584 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2014 | 2014 | ||||||||
|
solute carrier family 39 member 8 | 0.584 | 0.769 | 0.67 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
ribonucleotide reductase regulatory subunit M2 | 0.555 | 0.769 | 0.30 |
|
phenotype | 0.100 | None | 1.000 | 1 | 4 | 2011 | 2011 | ||||||||
|
pleckstrin homology and RhoGEF domain containing G1 | 0.890 | 0.115 | 1.3E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
potassium calcium-activated channel subfamily M alpha 1 | 0.518 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
SH2B adaptor protein 3 | 0.527 | 0.692 | 1.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
chloride voltage-gated channel 6 | 0.769 | 0.231 | 6.1E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
solute carrier family 24 member 4 | 0.751 | 0.346 | 2.2E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
chromodomain Y like 2 | 0.931 | 0.077 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
zinc finger protein 831 | 0.792 | 0.192 | 7.9E-10 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
Rho GTPase activating protein 42 | 0.792 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2011 | 2019 | ||||||||
|
FYVE, RhoGEF and PH domain containing 5 | 0.780 | 0.346 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
death associated protein kinase 1 | 0.472 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 8 | 2011 | 2011 | ||||||||
|
kelch like family member 32 | 0.931 | 0.115 | 9.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
phospholipase C delta 3 | 0.805 | 0.462 | 1.3E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2011 | 2011 |